Becton, Dickinson and Co., commonly known as BD, has reached a settlement agreement resolving numerous lawsuits concerning hernia mesh products developed by its subsidiary, Bard. The litigation concludes nearly 25,000 cases within federal multidistrict litigation and over 15,000 actions in state courts situated in Rhode Island, where Bard is headquartered.
The large-scale resolution is indicative of the ongoing challenges faced by medical device manufacturers in managing product liability claims. This settlement highlights the complexities and legal risks associated with medical devices, underscoring the necessity for stringent quality control and regulatory compliance. For further details, legal professionals can access the source of this information.